To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

ZIKA VIRUS

TODAY'S HEADLINES

Zika blood guidelines: 5 things to know

FDA's new guidelines on US blood transmissions aims to stem the spread of Zika virus. Read more

AstraZeneca drug a breakthrough in treatment of bladder cancer

FDA has granted breakthrough therapy designation for AstraZeneca's investigational drug, durvalumab, for bladder cancer. Read more

CONTINUING PHARMACY EDUCATION

Part 1: Recognition and referral to enhance recovery: The pharmacist's role in managing opioid use disorder

This month's CE activity is open for pharmacists and pharmacy technicians, "Part 1: Recognition and referral to enhance recovery: The pharmacist's role in managing opioid use disorder." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

[BLOG]: Pain management: Can we balance patient access, safety and economic value?

There are many complex reasons behind the fact that an estimated 40% to 70% of patients with chronic pain are not receiving proper medical treatment. Details

February 24, 2016

Related Articles

Top 5 things to know about Zika virus

Pharmacy companies underinvest in cancer drugs

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us